{"title":"125碘治疗甲亢疗效观察","authors":"C Glanzmann, W Horst","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>About 100 patients with hyperthyroidism and diffuse goiter (gland weight not more than 60 g) were treated with an individually calculated dose of 125-Iodine. After a follow-up time between 1.5 and 2 years there are the following results: 82% of the patients are euthyroid and 18% are still hyperthyroid. Relapse rate was 10%. More than 30% of the residual or relapse hyperfunctions were T3 toxicosis. The status of 125-Iodine in the treatment of thyrotoxicosis is discussed with regard to the necessity of a \"destructive\" therapy in the major part of the patients. Published results of 125-Iodine therapy are summarized.</p>","PeriodicalId":19324,"journal":{"name":"Nuclear-Medizin","volume":"14 3","pages":"207-18"},"PeriodicalIF":0.0000,"publicationDate":"1975-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Results of treatment of hyperthyroidism with 125-iodine].\",\"authors\":\"C Glanzmann, W Horst\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>About 100 patients with hyperthyroidism and diffuse goiter (gland weight not more than 60 g) were treated with an individually calculated dose of 125-Iodine. After a follow-up time between 1.5 and 2 years there are the following results: 82% of the patients are euthyroid and 18% are still hyperthyroid. Relapse rate was 10%. More than 30% of the residual or relapse hyperfunctions were T3 toxicosis. The status of 125-Iodine in the treatment of thyrotoxicosis is discussed with regard to the necessity of a \\\"destructive\\\" therapy in the major part of the patients. Published results of 125-Iodine therapy are summarized.</p>\",\"PeriodicalId\":19324,\"journal\":{\"name\":\"Nuclear-Medizin\",\"volume\":\"14 3\",\"pages\":\"207-18\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1975-08-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nuclear-Medizin\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nuclear-Medizin","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
[Results of treatment of hyperthyroidism with 125-iodine].
About 100 patients with hyperthyroidism and diffuse goiter (gland weight not more than 60 g) were treated with an individually calculated dose of 125-Iodine. After a follow-up time between 1.5 and 2 years there are the following results: 82% of the patients are euthyroid and 18% are still hyperthyroid. Relapse rate was 10%. More than 30% of the residual or relapse hyperfunctions were T3 toxicosis. The status of 125-Iodine in the treatment of thyrotoxicosis is discussed with regard to the necessity of a "destructive" therapy in the major part of the patients. Published results of 125-Iodine therapy are summarized.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
